Halozyme Therapeutics, Inc. (Halozyme) today announced that Johnson & Johnson has received approval from the U.S. Food and Drug Administration (FDA) for TECVAYLI® (teclistamab-cqyv) in combination ...
ADDITION OF DRILL-READY PROJECT WITH HISTORICAL SILVER RESOURCE1 AND MULTIPLE DISCOVERY TARGETS TONOPAH, Nev., March 6, 2026 /CNW/ - A2Gold Corp.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results